Cargando…

Changes in mortality among patients with chronic obstructive pulmonary disease from the 1990s to the 2000s: a pooled analysis of two prospective cohort studies

OBJECTIVES: This study aimed to identify and investigate changes in the mortality of patients with chronic obstructive pulmonary disease (COPD) at the same institute from the 1990s to the 2000s. We hypothesised that the improvement in long-term mortality of COPD was achieved due to the development o...

Descripción completa

Detalles Bibliográficos
Autores principales: Sato, Susumu, Oga, Toru, Muro, Shigeo, Tanimura, Kazuya, Tanabe, Naoya, Nishimura, Koichi, Hirai, Toyohiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10008372/
https://www.ncbi.nlm.nih.gov/pubmed/36882247
http://dx.doi.org/10.1136/bmjopen-2022-065896
_version_ 1784905744015949824
author Sato, Susumu
Oga, Toru
Muro, Shigeo
Tanimura, Kazuya
Tanabe, Naoya
Nishimura, Koichi
Hirai, Toyohiro
author_facet Sato, Susumu
Oga, Toru
Muro, Shigeo
Tanimura, Kazuya
Tanabe, Naoya
Nishimura, Koichi
Hirai, Toyohiro
author_sort Sato, Susumu
collection PubMed
description OBJECTIVES: This study aimed to identify and investigate changes in the mortality of patients with chronic obstructive pulmonary disease (COPD) at the same institute from the 1990s to the 2000s. We hypothesised that the improvement in long-term mortality of COPD was achieved due to the development of pharmacological and non-pharmacological treatments. DESIGN: This study was a retrospective analysis of two observational prospective cohort studies. One study enrolled subjects from 1995 to 1997 (the 1990s), and the other enrolled subjects from 2005 to 2009 (the 2000s). SETTING: Two studies from a single centre, which was the same university hospital in Japan. PARTICIPANTS: Patients with stable COPD. PRIMARY AND SECONDARY OUTCOME MEASURES: We analysed all-cause mortality data from the pooled database. Subanalyses were conducted by stratifying subjects into two groups according to airflow limitation severity as severe/very severe (per cent predicted value of forced expiratory volume in 1 s (%FEV(1)) <50%) or mild/moderate (%FEV(1)≥50%). RESULTS: In total, 280 male patients with COPD were enrolled. Patients in the 2000s (n=130) were significantly older (71.6 vs 68.7 years) and had milder disease (%FEV(1); 57.6% vs 47.1%) than those in the 1990s (n=150). Almost all severe/very severe patients in the 2000s received long-acting bronchodilators (LABDs), and they had a significantly lower risk of mortality than those in the 1990s according to Cox proportional regression analyses (OR=0.34, 95% CI 0.13–0.78), with a 48% reduction in 5-year mortality (from 31.0% to 16.1%). Moreover, any LABD use had a significantly positive impact on prognosis, even after adjustments for age, FEV(1), smoking status, dyspnoea, body size, oxygen therapy and study period. CONCLUSIONS: Trends indicating a better prognosis for patients with COPD in the 2000s were observed. This improvement may be associated with the usage of LABDs.
format Online
Article
Text
id pubmed-10008372
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-100083722023-03-13 Changes in mortality among patients with chronic obstructive pulmonary disease from the 1990s to the 2000s: a pooled analysis of two prospective cohort studies Sato, Susumu Oga, Toru Muro, Shigeo Tanimura, Kazuya Tanabe, Naoya Nishimura, Koichi Hirai, Toyohiro BMJ Open Respiratory Medicine OBJECTIVES: This study aimed to identify and investigate changes in the mortality of patients with chronic obstructive pulmonary disease (COPD) at the same institute from the 1990s to the 2000s. We hypothesised that the improvement in long-term mortality of COPD was achieved due to the development of pharmacological and non-pharmacological treatments. DESIGN: This study was a retrospective analysis of two observational prospective cohort studies. One study enrolled subjects from 1995 to 1997 (the 1990s), and the other enrolled subjects from 2005 to 2009 (the 2000s). SETTING: Two studies from a single centre, which was the same university hospital in Japan. PARTICIPANTS: Patients with stable COPD. PRIMARY AND SECONDARY OUTCOME MEASURES: We analysed all-cause mortality data from the pooled database. Subanalyses were conducted by stratifying subjects into two groups according to airflow limitation severity as severe/very severe (per cent predicted value of forced expiratory volume in 1 s (%FEV(1)) <50%) or mild/moderate (%FEV(1)≥50%). RESULTS: In total, 280 male patients with COPD were enrolled. Patients in the 2000s (n=130) were significantly older (71.6 vs 68.7 years) and had milder disease (%FEV(1); 57.6% vs 47.1%) than those in the 1990s (n=150). Almost all severe/very severe patients in the 2000s received long-acting bronchodilators (LABDs), and they had a significantly lower risk of mortality than those in the 1990s according to Cox proportional regression analyses (OR=0.34, 95% CI 0.13–0.78), with a 48% reduction in 5-year mortality (from 31.0% to 16.1%). Moreover, any LABD use had a significantly positive impact on prognosis, even after adjustments for age, FEV(1), smoking status, dyspnoea, body size, oxygen therapy and study period. CONCLUSIONS: Trends indicating a better prognosis for patients with COPD in the 2000s were observed. This improvement may be associated with the usage of LABDs. BMJ Publishing Group 2023-03-07 /pmc/articles/PMC10008372/ /pubmed/36882247 http://dx.doi.org/10.1136/bmjopen-2022-065896 Text en © Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) .
spellingShingle Respiratory Medicine
Sato, Susumu
Oga, Toru
Muro, Shigeo
Tanimura, Kazuya
Tanabe, Naoya
Nishimura, Koichi
Hirai, Toyohiro
Changes in mortality among patients with chronic obstructive pulmonary disease from the 1990s to the 2000s: a pooled analysis of two prospective cohort studies
title Changes in mortality among patients with chronic obstructive pulmonary disease from the 1990s to the 2000s: a pooled analysis of two prospective cohort studies
title_full Changes in mortality among patients with chronic obstructive pulmonary disease from the 1990s to the 2000s: a pooled analysis of two prospective cohort studies
title_fullStr Changes in mortality among patients with chronic obstructive pulmonary disease from the 1990s to the 2000s: a pooled analysis of two prospective cohort studies
title_full_unstemmed Changes in mortality among patients with chronic obstructive pulmonary disease from the 1990s to the 2000s: a pooled analysis of two prospective cohort studies
title_short Changes in mortality among patients with chronic obstructive pulmonary disease from the 1990s to the 2000s: a pooled analysis of two prospective cohort studies
title_sort changes in mortality among patients with chronic obstructive pulmonary disease from the 1990s to the 2000s: a pooled analysis of two prospective cohort studies
topic Respiratory Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10008372/
https://www.ncbi.nlm.nih.gov/pubmed/36882247
http://dx.doi.org/10.1136/bmjopen-2022-065896
work_keys_str_mv AT satosusumu changesinmortalityamongpatientswithchronicobstructivepulmonarydiseasefromthe1990stothe2000sapooledanalysisoftwoprospectivecohortstudies
AT ogatoru changesinmortalityamongpatientswithchronicobstructivepulmonarydiseasefromthe1990stothe2000sapooledanalysisoftwoprospectivecohortstudies
AT muroshigeo changesinmortalityamongpatientswithchronicobstructivepulmonarydiseasefromthe1990stothe2000sapooledanalysisoftwoprospectivecohortstudies
AT tanimurakazuya changesinmortalityamongpatientswithchronicobstructivepulmonarydiseasefromthe1990stothe2000sapooledanalysisoftwoprospectivecohortstudies
AT tanabenaoya changesinmortalityamongpatientswithchronicobstructivepulmonarydiseasefromthe1990stothe2000sapooledanalysisoftwoprospectivecohortstudies
AT nishimurakoichi changesinmortalityamongpatientswithchronicobstructivepulmonarydiseasefromthe1990stothe2000sapooledanalysisoftwoprospectivecohortstudies
AT hiraitoyohiro changesinmortalityamongpatientswithchronicobstructivepulmonarydiseasefromthe1990stothe2000sapooledanalysisoftwoprospectivecohortstudies